# Darren K. McGuire

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/darren-k-mcguire/

## Facts

| Field | Value |
| --- | --- |
| Citations | 110,798 |
| Field | Diabetes Treatment and Management |
| h-index | 119 |
| i10-index | 398 |
| OpenAlex ID | https://openalex.org/A5071945904 |
| ORCID iD | 0000-0002-6412-7989 |
| Works | 794 |

## Researcher papers

Showing 12 of 48.

- [Heart disease and stroke statistics--2015 update: a report from the American Heart Association.](https://scholariq.org/papers/heart-disease-and-stroke-statistics-2015-update-a-report-from-the-american-heart/)
- [Heart Disease and Stroke Statistics—2016 Update](https://scholariq.org/papers/heart-disease-and-stroke-statistics-2016-update/)
- [Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes](https://scholariq.org/papers/dapagliflozin-and-cardiovascular-outcomes-in-type-2-diabetes/)
- [Heart Disease and Stroke Statistics—2015 Update](https://scholariq.org/papers/heart-disease-and-stroke-statistics-2015-update/)
- [Heart Disease and Stroke Statistics—2014 Update](https://scholariq.org/papers/heart-disease-and-stroke-statistics-2014-update/)
- [Heart Disease and Stroke Statistics—2013 Update](https://scholariq.org/papers/heart-disease-and-stroke-statistics-2013-update/)
- [Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus](https://scholariq.org/papers/saxagliptin-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes/)
- [SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials](https://scholariq.org/papers/sglt2-inhibitors-for-primary-and-secondary-prevention-of-cardiovascular-and/)
- [Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes](https://scholariq.org/papers/effect-of-sitagliptin-on-cardiovascular-outcomes-in-type-2-diabetes/)
- [Executive Summary: Heart Disease and Stroke Statistics—2016 Update](https://scholariq.org/papers/executive-summary-heart-disease-and-stroke-statistics-2016-update/)
- [Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure](https://scholariq.org/papers/sotagliflozin-in-patients-with-diabetes-and-recent-worsening-heart-failure/)
- [Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial](https://scholariq.org/papers/albiglutide-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes-and/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.